...
首页> 外文期刊>Saudi Pharmaceutical Journal >Morin attenuates high-fat diet induced-obesity related vascular endothelial dysfunction in Wistar albino rats
【24h】

Morin attenuates high-fat diet induced-obesity related vascular endothelial dysfunction in Wistar albino rats

机译:Morin衰减Wistar Albino大鼠的高脂饮食诱导肥胖相关的血管内皮功能障碍

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Vascular endothelial dysfunction is caused by dyslipidemia, hypertension, and deficiency of antioxidant systems. In this study, the protective effect of a flavonol, morin was investigated in high-fat diet (HFD)-induced dyslipidemia and vascular endothelium dysfunction. The dose-dependent attenuating effect of morin was tested at doses of 50 and 100?mg/kg/day in an in-vivo model of HFD-induced dyslipidemia using rats whereas vascular endothelial reactivity was assessed in isolated rat aorta using ex-vivo organ bath setup. Morin administration in HFD-induced dyslipidemic rats for three weeks, resulted in a significant decrease in the body weight, LW/BW ratio as compared to rats treated with HFD only where the increase in body weight was observed. Significant reduction in the waist, BMI and lee index was also observed after morin treatment in HFD-induced dyslipidemic rats. In the lipid profile studies, HFD group showed a significant increase in the total cholesterol, triglyceride, LDL, and VLDL levels while HDL levels were decreased significantly, whereas morin treatment reversed all these parameters which were comparable to standard diet (SD) group. In the ex-vivo isolated aorta studies, HFD-induced endothelium dysfunction was observed, whereas it was reversed in the aorta of animals treated with morin at doses of 50 and 100?mg/kg/day, comparable to SD group. Morin treatment produced dose-dependent improvement in lipid profile and vascular endothelium protection, thus rationalizing its medicinal use in dyslipidemia and cardiovascular-related endothelial disorders.
机译:血管内皮功能障碍是由血脂血症,高血压和抗氧化系统缺乏引起的。在这项研究中,在高脂饮食(HFD) - 诱导的血脂血症和血管内皮功能障碍中研究了黄酮醇,MORIN的保护作用。使用大鼠在HFD诱导的血脂血症的体内模型中以50和100μmg/ kg /天的剂量测试Morin的剂量依赖性衰减效果,而使用前体内器官,在分离的大鼠主动脉中评估血管内皮反应性的血管内皮反应性浴设置。在HFD诱导的渗滤性大鼠中莫林施用三周,导致体重的显着降低,与用HFD处理的大鼠相比,只有在观察到体重的增加的大鼠相比。在HFD诱导的血脂血磷大鼠Morin治疗后,还观察到腰部的显着减少,BMI和Lee指数。在脂质分析研究中,HFD组显示出总胆固醇,甘油三酯,LDL和VLDL水平的显着增加,而HDL水平显着下降,而Morin治疗逆转所有与标准饮食(SD)组相当的这些参数。在前体内分离的主动脉研究中,观察HFD诱导的内皮功能障碍,而在用50-100×20μg/ kg /天的剂量为Morin处理的动物的主动脉中逆转,与SD组相当。 Morin治疗产生了脂质型材和血管内皮保护剂的剂量依赖性改善,从而使其在血吸虫血症和心血管相关内皮病症中的药用用途。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号